Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada

Search

Access to Cannabis for Medical Purposes Regulations

Version of section 84 from 2016-08-24 to 2018-10-16:


Marginal note:Product label — marihuana or cannabis oil

  •  (1) A licensed producer who sells or provides fresh or dried marihuana or cannabis oil under subsection 22(4) must ensure that a label that contains the following information and the information set out in subsection (2), (3) or (4), as applicable, is affixed to the immediate container:

    • (a) the name, telephone number and email address of the licensed producer;

    • (b) the words “Fresh marihuana / Marihuana fraîche”, “Dried marihuana / Marihuana séchée” or “Cannabis oil / Huile de chanvre indien” (or the equivalent term “Cannabis oil / Huile de cannabis”), as applicable;

    • (c) in respect of the substance in the container,

      • (i) its brand name,

      • (ii) its lot number, preceded by one of the following designations:

        • (A) “Lot number”,

        • (B) “Lot no.”,

        • (C) “Lot”, or

        • (D) “(L)”,

      • (iii) its recommended storage conditions,

      • (iv) its packaging date, and

      • (v) either

        • (A) its expiry date established in accordance with section 91, or

        • (B) a statement that no expiry date has been determined;

    • (d) the symbol “N” set out in the upper left quarter of the label in a colour contrasting with the rest of the label or in type not less than half the size of any other letters used on the label;

    • (e) the warning “KEEP OUT OF REACH OF CHILDREN / TENIR HORS DE LA PORTÉE DES ENFANTS”; and

    • (f) the statement “Important: Please read the Health Canada document provided with this package before using this product. / Important : Veuillez lire le document de Santé Canada qui accompagne ce colis avant d’utiliser ce produit.”.

  • Marginal note:Fresh or dried marihuana

    (2) In the case of fresh or dried marihuana, the label must also contain the following information in respect of the marihuana in the container:

    • (a) its net weight in grams;

    • (b) the percentage of delta-9-tetrahydrocannabinol w/w, followed by the word “delta-9-tetrahydrocannabinol”;

    • (c) the percentage of delta-9-tetrahydrocannabinol w/w that the marihuana could yield, taking into account the potential to convert delta-9-tetrahydrocannabinolic acid into delta-9-tetrahydrocannabinol;

    • (d) the percentage of cannabidiol w/w, followed by the word “cannabidiol”;

    • (e) the percentage of cannabidiol w/w that the marihuana could yield, taking into account the potential to convert cannabidiolic acid into cannabidiol; and

    • (f) in the case of fresh marihuana, the dried marihuana equivalency factor determined under section 79.

  • Marginal note:Oil other than in dosage form

    (3) In the case of cannabis oil that is not sold in a capsule or similar dosage form, the label must also contain the following information in respect of the oil in the container:

    • (a) its net weight in grams;

    • (b) its net volume in millilitres;

    • (c) the quantity of delta-9-tetrahydrocannabinol, in milligrams per millilitre;

    • (d) the quantity of delta-9-tetrahydrocannabinol, in milligrams per millilitre, that the oil could yield, taking into account the potential to convert delta-9-tetrahydrocannabinolic acid into delta-9-tetrahydrocannabinol;

    • (e) the quantity of cannabidiol, in milligrams per millilitre;

    • (f) the quantity of cannabidiol, in milligrams per millilitre, that the oil could yield, taking into account the potential to convert cannabidiolic acid into cannabidiol;

    • (g) the dried marihuana equivalency factor determined under section 79;

    • (h) the carrier oil used;

    • (i) the name of any food allergen, within the meaning of subsection B.01.010.1(1) of the Food and Drug Regulations, that is contained in the oil; and

    • (j) in the case of cannabis oil that is intended for topical use only, the warning “FOR TOPICAL USE ONLY. DO NOT INGEST. / POUR USAGE TOPIQUE SEULEMENT. NE PAS INGÉRER.”.

  • Marginal note:Oil in dosage form

    (4) In the case of cannabis oil that is sold in a capsule or similar dosage form, the label must also contain the following information in respect of the oil in the container:

    • (a) the number of capsules or units of that dosage form;

    • (b) the net weight in grams as well as the net volume in millilitres of each capsule or unit;

    • (c) the quantity of delta-9-tetrahydrocannabinol, in milligrams, in each capsule or unit;

    • (d) the quantity of delta-9-tetrahydrocannabinol, in milligrams, that each capsule or unit could yield, taking into account the potential to convert delta-9-tetrahydrocannabinolic acid into delta-9-tetrahydrocannabinol;

    • (e) the quantity of cannabidiol, in milligrams, in each capsule or unit;

    • (f) the quantity of cannabidiol, in milligrams, that each capsule or unit could yield, taking into account the potential to convert cannabidiolic acid into cannabidiol;

    • (g) the dried marihuana equivalency factor determined under section 79;

    • (h) the carrier oil used;

    • (i) the name of any food allergen, within the meaning of subsection B.01.010.1(1) of the Food and Drug Regulations, that is contained in the oil; and

    • (j) in the case of cannabis oil that is intended for topical use only, the warning “FOR TOPICAL USE ONLY. DO NOT INGEST. / POUR USAGE TOPIQUE SEULEMENT. NE PAS INGÉRER.”.


Date modified: